Commonwealth Equity Services’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$163K Buy
38,470
+9,226
+32% +$41.3K ﹤0.01% 4058
2025
Q4
$110K Buy
29,244
+13,390
+84% +$26K ﹤0.01% 4100
2025
Q3
$26K Sell
15,854
-3,394
-18% -$6.05K ﹤0.01% 4198
2025
Q2
$42K Buy
19,248
+7,094
+58% +$10.9K ﹤0.01% 4167
2025
Q1
$13K Buy
12,154
+100
+0.8% +$119 ﹤0.01% 4142
2024
Q4
$13K Sell
12,054
-3,500
-23% -$4K ﹤0.01% 4060
2024
Q3
$19K Hold
15,554
﹤0.01% 4003
2024
Q2
$19K Buy
15,554
+1,500
+11% +$2.04K ﹤0.01% 3975
2024
Q1
$14K Buy
14,054
+1,640
+13% +$1.38K ﹤0.01% 3976
2023
Q4
$13K Hold
12,414
﹤0.01% 3848
2023
Q3
$20K Hold
12,414
﹤0.01% 3735
2023
Q2
$19K Buy
+12,414
New +$19.9K ﹤0.01% 3753
2018
Q1
Sell
-25
Closed -$10K 2771
2017
Q4
$10K Buy
+25
New +$12.1K ﹤0.01% 2666

Other funds holding SLS